Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-09-000122
Filing Date
2009-02-05
Accepted
2009-02-05 15:56:07
Documents
2
Period of Report
2009-01-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 4533
2 poagrais.htm EX-24 6051
  Complete submission text file 0001123292-09-000122.txt   12627
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 650-854-8585
Grais Linda S (Reporting) CIK: 0001413306 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 09573029